Profiel
Dr. Gillinov brings a wealth of experience to Foundation Medical Partners.
He is an internationally recognized cardiac surgeon and innovator.
He holds the Judith Dion Pyle Chair in Heart Valve Research and is principle investigator of The Atrial Fibrillation Innovation Center, a $23 million program funded by the State of Ohio.
He has extensive experience with the development and assessment of new cardiovascular therapies, and is a founder of Viacor, Inc, a venture-funded company developing percutaneous approaches to mitral valve repair and Pleuraflow, LLC, which focuses on development of new, more effective techniques for surgical drainage.
He is also co-developer of the left atrial appendage clip, a novel medical device designed for open or minimally invasive occlusion of the left atrial appendage.
After graduating summa cum laude from Yale University, Dr. Gillinov entered Johns Hopkins University School of Medicine where he ranked first in his class.
He received his clinical and advanced training in general surgery and cardiac and thoracic surgery at The Johns Hopkins Hospital.
In 1997, after completing his education and training, he joined the Cleveland Clinic cardiac surgery staff.
Eerdere bekende functies van A. Marc Gillinov
| Bedrijven | Functie | Einde |
|---|---|---|
Viacor, Inc.
 Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Oprichter | 04-04-2012 |
ClearFlow, Inc.
 ClearFlow, Inc. Medical SpecialtiesHealth Technology ClearFlow, Inc. develops surgical and medical devices. Its products are based on proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage. The company was founded by Andrew D. Firlik, Marc A. Gillinov and Edward M. Boyle Jr. in 2006 and is headquartered in Irvine, CA. | Oprichter | - |
Cleveland Clinic Hospital
 Cleveland Clinic Hospital Hospital/Nursing ManagementHealth Services Part of Caris Life Sciences, LLC, Cleveland Clinic Hospital is a general and surgical hospital. The company is based in Weston, FL. Cleveland Clinic Hospital was acquired by The Cleveland Clinic Foundation, a subsidiary of Caris Life Sciences, LLC from Tenet Healthcare Corp. on October 02, 2006. | Corporate Officer/Principal | - |
Foundation Medical Partners
 Foundation Medical Partners Investment ManagersFinance Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic | Private Equity Investor | - |
Opleiding van A. Marc Gillinov
| The Johns Hopkins University | Undergraduate Degree |
| Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Health Technology |
ClearFlow, Inc.
ClearFlow, Inc. Medical SpecialtiesHealth Technology ClearFlow, Inc. develops surgical and medical devices. Its products are based on proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage. The company was founded by Andrew D. Firlik, Marc A. Gillinov and Edward M. Boyle Jr. in 2006 and is headquartered in Irvine, CA. | Health Technology |
Foundation Medical Partners
Foundation Medical Partners Investment ManagersFinance Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic | Finance |
Cleveland Clinic Hospital
Cleveland Clinic Hospital Hospital/Nursing ManagementHealth Services Part of Caris Life Sciences, LLC, Cleveland Clinic Hospital is a general and surgical hospital. The company is based in Weston, FL. Cleveland Clinic Hospital was acquired by The Cleveland Clinic Foundation, a subsidiary of Caris Life Sciences, LLC from Tenet Healthcare Corp. on October 02, 2006. | Health Services |
